ResearcherTaizhou Municipal HospitalActive in the last 2 years

Wei Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5152976935. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Microfluidic Gd3+-chelated hydrogel microspheres enable MRI-visible, image-guided photothermal chemotherapy for pancreatic cancer. Co-author DOI 10.1016/j.colsurfb.2026.115725 ↗
Inhibition of glutathione metabolism can limit the development of pancreatic cancer. Last author DOI 10.4252/wjsc.v14.i5.362 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Binhui Wang · 1 shared paper, 2026 · strength 0.36
- Paper Microfluidic Gd3+-chelated hydrogel microspheres enable MRI-visible, image-guided photothermal chemotherapy for pancrea… DOI 10.1016/j.colsurfb.2026.115725 ↗
Yan Wang · 1 shared paper, 2022 · strength 0.17
- Paper Inhibition of glutathione metabolism can limit the development of pancreatic cancer. DOI 10.4252/wjsc.v14.i5.362 ↗
Peiyuan Cai · 1 shared paper, 2022 · strength 0.17
- Paper Inhibition of glutathione metabolism can limit the development of pancreatic cancer. DOI 10.4252/wjsc.v14.i5.362 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.